Ruchita Sinha
General Partner at AV8 Ventures
Ruchita Sinha
General Partner at AV8 Ventures
San Francisco Bay Area
Overview
Work Experience
General Partner
2019 - Current
Build and lead life science and healthcare investment practice. Invest in seed and Series A companies at the intersection of life science and tech. Investor and/or board member in: ⬩Axuall ⬩Brave Care ⬩Clever Care ⬩CuraFi ⬩Flourish Health ⬩Phenomic AI ⬩Shennon Bio ⬩SimBioSys ⬩Think Bioscience ⬩Yuvo Health
Advisor
2019 - 2020
Mahana Therapeutics joins technology and healthcare expertise to produce innovative and cutting-edge digital therapeutics products https://www.mahanatherapeutics.com/
Sr. Director of Investments
2016 - 2019
Help manage venture fund focused on investing in biotech, healthcare technology & services. Lead and manage biotech and digital health investments for corporate fund. As head of healthtech and science platforms, build out investment practice for the fund. Investors and/or board member in: ⬩Inozyme Pharma (INZY) ⬩Evidation Health ⬩Omada Health ⬩Click Therapeutics ⬩Curisium ⬩Aetion
Director, GE Ventures
2013 - 2016
Led and supported a range of initiatives with startups and GE including equity investments, partnerships, and portfolio management. Investor and/or board member in: ⬩Caremerge ⬩WinguMD ⬩Jiseki Health ⬩HeadSense
Director, Strategy, Portfolio Management, and Commercial Operations
2010 - 2013
Business development, strategic planning and portfolio management for multiple therapeutic areas including cardiovascular, diabetes, and oncology. - Lead and participate in both inorganic and organic drug development initiatives for specific business units, as well as, enterprise-level corporate strategy projects.
Sr. Consultant
2007 - 2010
Responsible for managing teams and working with senior management (VP/C-level) to deliver significant impact in strategy, business development, and sales & marketing for pharmaceutical, biotech, medical device, and medical diagnostic clients. Developed enterprise-level and business unit-level strategy, new product plans, and go-to-market strategies.
Research Associate
2001 - 2005
Member of molecular biology team responsible for identifying novel drug targets for internal and external research projects using Maxygen’s proprietary molecular breeding technology.